Participating COOPT Faculty

Aravind AsokanAravind Asokan, PhD 
Dr. Asokan engineers biological macromolecules and viruses for human gene therapy. 

 

Asokan Lab 


Pranam ChatterjeePranam Chatterjee, PhD (beginning July 1, 2022)

Dr. Chatterjee develops diverse algorithmic modalities to discover, characterize, and engineer novel proteins for applications in genome editing, targeted protein modulation, and reproductive bioengineering.

Chatterjee profile


 

maria ciofaniMaria Ciofani, PhD

Dr. Ciofani is interested in defining the transcriptional networks of T cell pathogenicity in autoimmune disease.

Ciofani Profile


Greg CrawfordGregory E. Crawford, PhD

Dr. Crawford's research involves identifying gene regulatory elements across the genome to help us understand how chromatin structure dictates cell function and fate. 

Crawford Lab


Yarui DiaoYarui Diao, PhD

Dr. Diao's research is focused on developing new functional genomics tools to study genome structure and function and using skeletal muscle regeneration and muscle stem cell as a model system to study gene regulation of tissue regeneration in health and diseases conditions.

Diao Lab


Charlie GersbachCharles Gersbach, PhD

Dr. Gersbach's research is dedicated to applying innovative methods in molecular and genetic engineering to regenerative medicine, treating genetic disease, and enhancing our understanding of fundamental biological processes. 

Gersbach Lab


Raluca GorânRaluca Gordân, PhD

Dr. Gordân's lab develops quantitative computational and experimental approaches to identify and characterize transcriptional regulatory regions in the human genome. 

Gordân Lab


Simon GregorySimon Gregory, PhD

Dr. Gregory is interested in elucidating the molecular mechanisms underlying multi-factorial diseases. His lab is primarily interested identifying the complex genetic factors that give rise to multiple sclerosis (MS) and autism.

Gregory Lab


Alex HarteminkAlexander Hartemink, PhD

Dr. Hartemink is interested in developing new algorithms in statistical machine learning and artificial intelligence and applying those methods to complex problems in computational genomics.

Hartemink Lab


David KirschDavid G. Kirsch, MD, PhD

Dr. Kirsch is interested in utilizing mouse models of cancer to study cancer and radiation biology in order to develop new cancer therapies in the pre-clinical setting.

Kirsch Lab


Anoop PatelAnoop Patel, MD

Dr. Patel focuses on using single cell technologies to understand tumor heterogeneity, with a special focus on malignant brain tumors. His lab is specifically interested in how heterogeneity contributes to treatment resistance and uses patient samples and complex model systems to study tumor evolution during therapy.


Ken PossKen Poss, PhD

Dr. Poss is interested in injury-induced regeneration of heart, spinal cored and appendages in zebrafish and exploratory methods to understand regeneration.

Poss Lab


Tim ReddyTim Reddy, PhD

Dr. Reddy is focused on understanding how genetic variation that alters gene regulation contributes to human traits including risk for common diseases such as diabetes. 

Reddy Lab


Purushothama Rao TataPurushothama Rao Tata, PhD

Dr. Tata is interested in defining gene regulatory networks in normal and pathological lung tissues at single cell resolution as well as using pharmacogenonmic apporaches to define signaling networks in lung stem cells.

Tata Lab


Jenny TungJenny Tung, PhD

Dr. Tung is interested in the social determinants of gene regulation in experimental animal models and wild pop